Robert I Griffiths

• The Relationship of Provider Organizational Status and Erythropoietin Dosing in End Stage Renal Disease Patients

  Gregory de Lissovoy, Neil R Powe et al.•ARTICLE•Medical Care•1994

  Incluir item

  Controversy exists as to whether provider organizational characteristics such as profit status and setting are associated with the content of medical care or efficiency with which care is rendered. Following FDA approval of human recombinant erythropoietin (EPO) for use in clinical practice, Medicare approved coverage for beneficiaries in its end stage renal disease program and established a fixed payment per dose. Because cost of EPO administrat…

• The Relationship of Provider Organizational Status and Erythropoietin Dosing in End Stage Renal Disease Patients

  Gregory de Lissovoy, Neil R Powe et al.•ARTICLE•Medical Care•1994

  Incluir item

  Controversy exists as to whether provider organizational characteristics such as profit status and setting are associated with the content of medical care or efficiency with which care is rendered. Following FDA approval of human recombinant erythropoietin (EPO) for use in clinical practice, Medicare approved coverage for beneficiaries in its end stage renal disease program and established a fixed payment per dose. Because cost of EPO administrat…

Business (1 obras) · Dialysis and Renal Disease Management (1 obras) · Dosing (1 obras) · Erythropoietin (1 obras) · Finance (1 obras) · Finance (1 obras) · Health Systems, Economic Evaluations, Quality of Life (1 obras) · Healthcare Policy and Management (1 obras) · Internal Medicine (1 obras) · Internal Medicine (1 obras)